Samil PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 3/6
Samil PharmaceuticalLtd has a total shareholder equity of ₩174.6B and total debt of ₩143.5B, which brings its debt-to-equity ratio to 82.2%. Its total assets and total liabilities are ₩384.2B and ₩209.6B respectively. Samil PharmaceuticalLtd's EBIT is ₩5.1B making its interest coverage ratio 4.2. It has cash and short-term investments of ₩4.0B.
Key information
82.2%
Debt to equity ratio
₩143.52b
Debt
| Interest coverage ratio | 4.2x |
| Cash | ₩4.00b |
| Equity | ₩174.65b |
| Total liabilities | ₩209.58b |
| Total assets | ₩384.23b |
Recent financial health updates
We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt
Sep 11
Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?
May 24Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Recent updates
Some Samil Pharmaceutical Co.,Ltd (KRX:000520) Shareholders Look For Exit As Shares Take 27% Pounding
Nov 18Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking
Sep 13We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt
Sep 11Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking
Jul 29Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?
May 24There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump
Mar 30Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality
Mar 21Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment
Mar 11Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?
Feb 15
Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?
Jan 20Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend
Dec 24Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment
Dec 09What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?
Nov 18Financial Position Analysis
Short Term Liabilities: A000520's short term assets (₩87.5B) do not cover its short term liabilities (₩116.1B).
Long Term Liabilities: A000520's short term assets (₩87.5B) do not cover its long term liabilities (₩93.5B).
Debt to Equity History and Analysis
Debt Level: A000520's net debt to equity ratio (79.9%) is considered high.
Reducing Debt: A000520's debt to equity ratio has reduced from 128.6% to 82.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A000520 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A000520 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 19.2% per year.